ATE107858T1 - Pharmazeutische zusammensetzung zum abnehmen. - Google Patents

Pharmazeutische zusammensetzung zum abnehmen.

Info

Publication number
ATE107858T1
ATE107858T1 AT90907185T AT90907185T ATE107858T1 AT E107858 T1 ATE107858 T1 AT E107858T1 AT 90907185 T AT90907185 T AT 90907185T AT 90907185 T AT90907185 T AT 90907185T AT E107858 T1 ATE107858 T1 AT E107858T1
Authority
AT
Austria
Prior art keywords
slimming
pharmaceutical composition
ephedrine
human
reducing
Prior art date
Application number
AT90907185T
Other languages
English (en)
Inventor
Arne Astrup
Original Assignee
Nycomed Dak As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Dak As filed Critical Nycomed Dak As
Application granted granted Critical
Publication of ATE107858T1 publication Critical patent/ATE107858T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Child & Adolescent Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90907185T 1989-07-07 1990-04-20 Pharmazeutische zusammensetzung zum abnehmen. ATE107858T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK339289A DK339289D0 (da) 1989-07-07 1989-07-07 Farmaceutisk praeparat

Publications (1)

Publication Number Publication Date
ATE107858T1 true ATE107858T1 (de) 1994-07-15

Family

ID=8122369

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90907185T ATE107858T1 (de) 1989-07-07 1990-04-20 Pharmazeutische zusammensetzung zum abnehmen.

Country Status (18)

Country Link
US (1) US5422352A (de)
EP (1) EP0480934B1 (de)
JP (1) JP2584899B2 (de)
KR (1) KR0159045B1 (de)
AT (1) ATE107858T1 (de)
AU (1) AU638992B2 (de)
CA (1) CA2063598C (de)
DE (1) DE69010336T2 (de)
DK (2) DK339289D0 (de)
ES (1) ES2055911T3 (de)
FI (1) FI920026A7 (de)
HU (1) HU220071B (de)
LT (1) LT3536B (de)
LV (1) LV10192B (de)
NO (1) NO920051L (de)
RU (1) RU2109511C1 (de)
UA (1) UA27779C2 (de)
WO (1) WO1991000730A1 (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5865869A (en) * 1991-08-02 1999-02-02 Ecologel Usa, Inc. Solution for plant root watering
WO1994000432A1 (en) * 1992-06-30 1994-01-06 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Anorectic epinephrine derivatives
EP0671936A1 (de) * 1992-10-15 1995-09-20 Dana-Farber Cancer Institute, Inc. Behandlung der insulinresistenz bei mit übergewicht verbundenem type ii-diabetes mittels antogonisten gegen die funktion von tnf-g(a)
ES2094687B1 (es) * 1994-08-02 1997-12-16 S A L V A T Lab Sa Combinacion farmaceutica contra la obesidad o el sobrepeso.
FR2746644A1 (fr) * 1996-03-18 1997-10-03 Firion Jackie Produit parapharmaceutique moderateur d'appetit
US6224873B1 (en) 1996-09-30 2001-05-01 Zhishin, Llc Regulation of appetite, body weight and athletic function with materials derived from citrus varieties
ES2339908T3 (es) * 1996-09-30 2010-05-26 Dennis Jones Regulacion del peso corporal con materiales derivados de variedades del genero de citricos.
DK0946155T4 (da) 1996-12-23 2009-05-11 Sla Pharma Ag Farmaceutisk sammensætning til behandling af fækal inkontinens
US6162455A (en) * 1997-01-22 2000-12-19 American Cyanamid Company Method for increasing lean meat, improving the lean meat to fat ratio and improving amino acid utilization in warm-blooded animals
US5985282A (en) * 1997-01-22 1999-11-16 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
US5798101A (en) * 1997-01-22 1998-08-25 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
HUP9700654A2 (hu) 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
US6468519B1 (en) * 1997-09-10 2002-10-22 Rutgers, The State University Of New Jersey Polyanhydrides with biologically active degradation products
NZ509198A (en) 1998-06-26 2002-11-26 Elaine A Treatment for multiple sclerosis using a histamine H2 agonist in combination with a phosphodiesterase inhibitor
US7232830B2 (en) 1998-06-26 2007-06-19 Elaine A Delack Method for treatment of neurodegenerative diseases and effects of aging
US6340482B1 (en) * 2000-05-18 2002-01-22 Zhishin, Llc Methods for inducing weight loss in a human with materials derived from Citrus varieties
US6113949A (en) * 1998-10-27 2000-09-05 Prolab Nutrition, Inc. Weight control product and method of treating hyperlipidemia and increasing vigor with said product
US6475514B1 (en) * 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
FR2788438B1 (fr) * 1999-01-14 2003-10-03 Arkopharma Laboratoires Composition pour le traitement de l'obesite et procede de traitement esthetique
US6576272B1 (en) * 1999-03-05 2003-06-10 Twin Laboratories Incorporated Dietary supplement and method of using same
AU6221500A (en) * 1999-07-20 2001-02-05 Natrol, Inc. Weight control product comprising a synergistic mixture of guggul extract, phosphate salt and metabolic stimulant
MXPA02001882A (es) * 1999-08-23 2002-08-20 Univ Tulane Modulacion del transportador de leptina a traves de la barrera hemato-encefalica.
US6723737B1 (en) * 1999-10-20 2004-04-20 Eliezer Rapaport Methods, pharmaceutical and therapeutic compostions for administering adenosine
US7115297B2 (en) * 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
DE10011541A1 (de) * 2000-03-06 2001-09-20 Reimann Hartmut Verwendung einer Kombination aus Ephedrin und Coffein und/oder Theophyllin zur Vitalisierung von Knochenfischen, Wasserzusatz zur Vitalisierung von Knochenfischen
US6316499B1 (en) 2000-05-18 2001-11-13 Zhishin, Llc Methods for increasing the muscle mass of a human with materials derived from citrus varieties
KR20030005204A (ko) * 2000-12-25 2003-01-17 가부시키가이샤 시세이도 교감신경 활성화 향료 조성물
US7048941B2 (en) * 2001-03-30 2006-05-23 New World Enterprizes, Inc. Chocolate composition as delivery system for nutrients and medications
WO2003022239A2 (en) * 2001-09-07 2003-03-20 Western Holdings Llc Stable water in oil aminophylline emulsions
RU2209582C2 (ru) * 2001-10-22 2003-08-10 Горелик Самуил Лейбович Способ контроля веса пациента
GB0130763D0 (en) 2001-12-21 2002-02-06 Norgine Res Ltd Treatment methods
WO2003088953A2 (en) * 2002-04-19 2003-10-30 N.V. Nutricia Multiphasic diet
US8142810B2 (en) * 2002-05-30 2012-03-27 The Procter & Gamble Company Dietary method for modulating glucose metabolism and associated conditions and increasing longevity
US20040077530A1 (en) * 2002-10-18 2004-04-22 Robert Portman Composition for reducing caloric intake
US20040224031A1 (en) * 2003-05-06 2004-11-11 Antonio Zorzano Olarte Combination of amines and vanadium (IV)/(V) compounds for the treatment and/or prevention of diabetes mellitus
CA2559836C (en) 2003-10-17 2014-08-12 Diet Formulations Ltd. Thermogenic and fiber containing weight-loss supplement
WO2005051092A2 (en) * 2003-11-20 2005-06-09 Alteragon Pty Ltd Method of decreasing fat deposits and body weight in mammals and birds
PL209905B1 (pl) * 2004-01-15 2011-11-30 Bringwell Internat Ab Preparat do leczenia otyłości i związanego z nią syndromu metabolicznego
CA2455248A1 (en) * 2004-01-29 2005-07-29 Alexander Zolotoy Oral administration of r-albuterol against obesity
US7524064B2 (en) * 2004-03-09 2009-04-28 Research Foundation Of The State University Of New York Apparatus and method for assessing retinal damage
US20060074057A1 (en) * 2004-10-04 2006-04-06 Eric Marchewitz Use of chenodeoxycholic acid for reducing adipose tissue
US20060134230A1 (en) * 2004-12-17 2006-06-22 Sal Abraham Weight loss composition and formulation
US20060204599A1 (en) * 2005-03-14 2006-09-14 Wheat Jared R Dietary supplement and method of using same
US20090214682A1 (en) * 2008-02-22 2009-08-27 Heuer Marvin A Composition and methods for weight loss in a subject
US9044606B2 (en) 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
US9610429B2 (en) * 2010-12-29 2017-04-04 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue with targeted substance delivery
US9271982B2 (en) 2012-10-08 2016-03-01 Rivalea (Australia) Pty Ltd. Animal feed supplement comprising ractopamine and caffeine
US9877434B2 (en) 2013-05-30 2018-01-30 Ecologel Solutions, Llc Granular compositions and methods for drought mitigation
AU2015234690B2 (en) * 2014-03-26 2019-08-29 Rivalea (Australia) Pty Ltd Method for improving feed efficiency in ruminants
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
US10080884B2 (en) 2014-12-29 2018-09-25 Ethicon Llc Methods and devices for activating brown adipose tissue using electrical energy
CN120436205A (zh) 2015-02-13 2025-08-08 马斯公司 包装宠物食物产品
WO2016167855A1 (en) * 2015-04-14 2016-10-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Combination of albuterol and caffeine as synergistic treatment for obesity or sarcopenia
GB201522296D0 (en) 2015-12-17 2016-02-03 Mars Inc Food product to reduce body fat
US11090278B2 (en) 2019-05-16 2021-08-17 Nexus Pharmaceuticals, Inc. Compositions comprising ephedrine or an ephedrine salt and methods of making and using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2390164A1 (fr) * 1977-05-13 1978-12-08 Blanie Paul Association a action anti-asthmatique
DE2743702A1 (de) 1977-06-03 1978-12-14 Pharmaceutical Export Promotio Abmagerungs- oder schlankmacher- zubereitung und verfahren zu ihrer herstellung
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
US4525359A (en) * 1982-12-10 1985-06-25 Greenway Frank L Iii Treatment for selective weight control
US5011843A (en) * 1988-05-31 1991-04-30 Iolab Corporation Treatment of glaucoma using phosphodiesterase inhibitors

Also Published As

Publication number Publication date
DK0480934T3 (da) 1994-11-07
WO1991000730A1 (en) 1991-01-24
CA2063598C (en) 1997-12-09
LV10192A (lv) 1994-10-20
DK339289D0 (da) 1989-07-07
HK1001821A1 (en) 1998-07-10
LT3536B (en) 1995-11-27
DE69010336T2 (de) 1994-11-03
HU9200051D0 (en) 1992-06-29
NO920051D0 (no) 1992-01-03
HUT62798A (en) 1993-06-28
HU220071B (hu) 2001-10-28
FI920026A0 (fi) 1992-01-03
ES2055911T3 (es) 1994-09-01
JPH04507091A (ja) 1992-12-10
AU5630890A (en) 1991-02-06
LTIP702A (en) 1995-01-31
CA2063598A1 (en) 1991-01-08
FI920026A7 (fi) 1992-01-03
JP2584899B2 (ja) 1997-02-26
NO920051L (no) 1992-01-31
RU2109511C1 (ru) 1998-04-27
EP0480934A1 (de) 1992-04-22
EP0480934B1 (de) 1994-06-29
KR0159045B1 (ko) 1998-12-01
AU638992B2 (en) 1993-07-15
UA27779C2 (uk) 2000-10-16
LV10192B (en) 1995-06-20
DE69010336D1 (de) 1994-08-04
US5422352A (en) 1995-06-06

Similar Documents

Publication Publication Date Title
DE69010336D1 (de) Pharmazeutische zusammensetzung zum abnehmen.
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
YU47543B (sh) Postupak za dobijanje farmaceutskog preparata za stimulaciju granulocita
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
DE68910159D1 (de) Dosierform für Verabreichung in der Humanmedizin.
NO924209L (no) Doseringsform for tilfoersel av et antiparkinsonmiddel
BR9006924A (pt) Formulacao para tratamento de sintomas e doencas,uso de formulacao para o tratamento de sintomas e doencas,metodo para o tratamento de sintomas e doencas,distribuicao de agentes medicinais e terapeuticos para o tratamento de sintomas e doencas e combinacao para administracao em mamiferos
PT977564E (pt) Forscolina para promocao da massa corporal magra
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
ATE78169T1 (de) Behandlung von diabetes durch kombinierte insulinformen.
SE8802569D0 (sv) Improvements in or relation to somatostatins
DE69637050D1 (de) Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer
NO305581B1 (no) Anvendelse av et benaktivt fosfonat i kombinasjon med et °strogenhormon, og preparat i enhetsdoseform for behandling av osteoporose
HU883863D0 (en) Process for the preparation of producing and/or portionly form of therapeutical agents
EP0214254A1 (de) Melatoninhaltige mittel sowie deren verwendungen.
DE69621243D1 (de) Verwendung von bradykininantagonisten zur induzierung oder stimulation des haarwachstums und/oder zur verlangsamung des haarausfalls
BG50159A3 (bg) Метод за получаване на производни на пиранобензоксадиазол
BE885793A (fr) Sels d'acides 6,7-dihalo-3,4-dihydro-3-oxo-2-quinoxalinecarboxyliques et d'amines steriquement encombrees, leur preparation et leur utilisation therapeutique
IL101675A (en) Method and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors
KR900007434A (ko) 시스타틴을 유효 성분으로하는 치료제
AR008155A1 (es) Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.
GB2004183A (en) Compositions containing caffeine and ephedrine or their derivatives
KR900017599A (ko) 종양 치료용 약학 조성물
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
ES2053834T3 (es) Un metodo para la preparacion de una sustancia terapeutica.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee